Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery-Reference-Cited by-同舟云学术

Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery

Published:2018-12-20 Issue:1 Volume:17 Page:52-62
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Peyvandi F.¹²,Mamaev A.³,Wang J.‐D.⁴,Stasyshyn O.⁵,Timofeeva M.⁶,Curry N.⁷,Cid A. R.⁸,Yee T. T.⁹,Kavakli K.¹⁰,Castaman G.¹¹,Sytkowski A.¹²

Affiliation:

1. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Angelo Bianchi Bonomi Hemophilia and Thrombosis CenterMilan Italy

2. Department of Pathophysiology and Transplantation University of Milan Milan Italy

3. Regional State Budgetary Healthcare Institution “Regional Clinical Hospital” Barnaul Altai Region Russian Federation

4. Center for Rare Diseases and Hemophilia Center Taichung Veterans General Hospital Taichung Taiwan

5. SI Institute of Blood Pathology and Transfusion Medicine of NAMS of Ukraine Lviv Ukraine

6. Federal State Budgetary Research Institution “Kirov Scientific and Research Institute of Hematology and Blood Transfusion of Federal Medico‐Biological Agency of Russia” Kirov Russian Federation

7. The Oxford Haemophilia and Thrombosis Centre Churchill Hospital and NIHR BRC, Blood Theme Oxford UK

8. Hospital Universitario y Politécnico La Fe Hemostasia y Trombosis Valencia Spain

9. Royal Free London NHS Foundation Trust Katharine Dormandy Haemophilia and Thrombosis Centre London UK

10. Ege Universitesi Tip Fakultesi Hematoloji Bilim Dali Bornova, Izmir Turkey

11. Center for Bleeding Disorders and Coagulation Department of Oncology Careggi University Hospital Florence Italy

12. Shire Cambridge MA USA

Funder

Baxalta

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14313

Reference24 articles.

1. Von Willebrand’s Disease

2. Treatment of von Willebrand's Disease

3. Comparative Analysis and Classification of von Willebrand Factor/Factor VIII Concentrates: Impact on Treatment of Patients with von Willebrand Disease

4. The function of ultra-large von Willebrand factor multimers in high shear flow controlled by ADAMTS13

5. Von Willebrand factor: molecular size and functional activity

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exposure–Response Relationship between VWF/FVIII Activity and Spontaneous Bleeding Events Following Recombinant VWF Prophylaxis in Severe VWD;TH Open;2024-04

2. Diagnosis and treatment of von Willebrand disease in 2024 and beyond;Haemophilia;2024-03-13

3. Progress in von Willebrand Disease Treatment: Evolution towards Newer Therapies;Seminars in Thrombosis and Hemostasis;2024-02-08

4. Abdominoplasty in a Patient With Type 3 von Willebrand Disease;Annals of Plastic Surgery;2023-10-23

5. Targeting von Willebrand disease: the current status and future directions of management therapies;Expert Review of Hematology;2023-10-12